Cúm là gì?

Pertussis (whooping cough) is a highly contagious, respiratory disease caused by an infection with the bacterium Bordetella ho gà. The bacteria attach to the cilia (tiny, hair-like structures) that line the upper respiratory system. The bacteria release toxins, which damage the cilia and cause airways to swell. Pertussis infection is usually more serious in infants under 6 tháng, but it can affect

of any age.

Cần để ý những gì

Symptoms begin 6 to 20 days after exposure and initially include rhinorrhoea (runny nose), malaise and a non-specific cough (the catarrhal phase). Approximately one week later, periods of coughing increase with intensity (the paroxysmal phase). A characteristic deep gasp (or “whoop”) may be heard on inspiration, but this is not present in all infections.

During or just following an episode of paroxysmal coughing, babies may have a period of apnoea where they stop breathing for a short period. This may be associated with some colour changes where their skin may appear blue or dusky, especially around the mouth.

Complications of pertussis in infants can include vomiting and difficulty feeding due to prolonged paroxysmal coughing episodes. Rare complications of pertussis in infants include pneumonia and encephalitis, which can be fatal. Complications in older children and adults can include fainting episodes, sleeplessness and rib fractures due to paroxysmal coughing episodes.

Bệnh lây truyền qua đường nào

Transmission of pertussis is through the inhalation of infected respiratory secretions that have been made airborne by coughing, sneezing and speaking. Pertussis is highly contagious, with one infected individual likely to transmit infection to 70–100% of their household members. Some people with mild symptoms of pertussis may be unaware they are infected, but can still spread the bacteria to others. Humans are the only known reservoir for pertussis.

The incubation period is 1 to 3 weeks. Without treatment, people with pertussis are considered infectious just prior to symptom onset and for 21 days thereafter. The infectious period is reduced to 5 days if a course of targeted antibiotics is completed.

Dịch tễ học

Australia has historically experienced pertussis epidemics every 3 to 4 years. There is a seasonal pattern to pertussis infections with most cases reported in the spring and summer months.

Infants under 6 months of age have the highest rates of hospitalisation and death from pertussis infection. Aboriginal and Torres Strait Islander children under 5 years have higher rates of pertussis infection and hospitalisation compared with non-Indigenous children of the same age.

The introduction of the maternal pertussis vaccination program in 2015 saw a significant reduction in young infants infected with pertussis and a substantial reduction in both morbidity and mortality associated with infection. Between 2016 and 2018, infants under 2 months of age had the lowest incidence of disease, and children aged 9 to 11 years had the highest incidence of disease.

Phòng ngừa

Vaccination against Bordetella ho gà is the most effective public health measure for the prevention of pertussis for both vaccine recipients (direct effect), and among unimmunised populations (indirect ‘herd’ effect)Vaccination of có thai

Mộtlso provideS short-term, passive protection to infants through the transplacental transfer of antibodies.

Pertussis vaccination is only available in Australia in combination with diphtheria and tetanus. Vaccines may also include protection against poliomyelitis, hepatitis B and haemophilus influenzae type B.

The pertussis vaccines available in Australia are acellular, meaning they are made using pertussis toxin and/or components of pertussis bacterium. In contrast, whole-cell pertussis vaccines are first generation pertussis vaccines that are made using an entire bacterium that has been inactivated. While whole cell pertussis vaccines are still available internationally, they were phased out in Australia in 1997, in favour of acellular pertussis vaccines.

khóa học chính

As per the National Immunisation Program (NIP), a primary course of pertussis vaccination is given at 6 weeks, 4 months, and 6 months of age (Infanrix hexa/Vaxelis).

tên lửa đẩy

Booster doses are scheduled to be administered at:

  • 18 months (Infanrix/Tripacel)
  • 4 years (Infanrix-IPV/Quadracel)
  • 12 to 13 years of age/Year 7 high school program (Boostrix/Adacel)
  • pregnant people at 20–32 weeks gestation (every pregnancy, regardless of how closely spaced).

In addition, pertussis vaccination is recommended (but not funded) for:

  • parents/guardians of a baby under 6 months of age (if they have not received a dose in the last 10 years)
  • adults aged 65 years and older who have not received a pertussis-containing vaccine in the last 10 years
  • any adult who wishes to be protected against pertussis infection who has not received a dose in the last 10 years (including healthcare workers, travellers, and early childhood educators and carers).
WordPress Tables Plugin

Grey shaded boxes – Not routinely recommended for use in this age group.
* ATAGI recommends the use of Infanrix hexaVaxelis in children aged < 10 years. However, the Royal Children’s Hospital (RCH) preferentially uses them up to < 18 years in instances where multiple vaccines are

(e.g. catch up, post chemotherapy/post HSCT). 

Tác dụng phụ của vắc-xin

Common side effects from pertussis vaccination include phản ứng tại chỗ tiêm, fever, lethargy, headache and irritability in infants and young children. Rare side effects include allergic reaction and hypotonic-hyporesponsive episode (HHE) in infants. There has been a decrease in the incidence of HHE following the change from whole-cell pertussis to acellular pertussis vaccines on the NIP.

Các tác giả: Mel Addison (SAEFVIC Research Nurse, Murdoch Children’s Research Institute), Rachael McGuire (SAEFVIC Research Nurse, Murdoch Children’s Research Institute) and Katie Butler (MVEC Education Nurse)

Đượcxem xét bởi: Rachael McGuire (Điều phối viên y tá giáo dục)

Ngày: September 2024

Tài liệu trong phần này được cập nhật khi có thông tin mới và có vắc-xin. Nhân viên của Trung Tâm Giáo Dục Vắc-xin Melbourne (MVEC) thường xuyên xem xét độ chính xác của các tài liệu.

Quý vị không nên coi thông tin tại trang mạng này là lời khuyên y tế chuyên nghiệp, cụ thể cho sức khỏe của riêng mình hoặc sức khỏe riêng của gia đình quý vị. Đối với những mối lo ngại về y tế, bao gồm các quyết định về chủng ngừa, thuốc men và các phương pháp điều trị khác, quý vị phải luôn hỏi ý kiến chuyên gia y tế.

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

Về MVEC

Trung tâm Giáo dục về Vắc xin Melbourne (MVEC) là một trang web giáo dục, được phát triển với mục đích cung cấp thông tin tiêm chủng cập nhật cho cả các chuyên gia chăm sóc sức khỏe và người dân. Chúng tôi có trụ sở tại Viện Nghiên cứu Trẻ em Murdoch (MCRI), một tổ chức nghiên cứu và có liên kết với SAEFVIC (Giám sát các Sự kiện Bất lợi Sau khi Tiêm chủng trong Cộng đồng), Dịch vụ An toàn Vắc xin Victoria.

Chia sẻ cái này